Talk:Sofosbuvir/velpatasvir/voxilaprevir

This is the talk page for discussing improvements to the Sofosbuvir/velpatasvir/voxilaprevir article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Sofosbuvir/velpatasvir/voxilaprevir.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Merge proposal[edit]

Moving the stub, Voxilaprevir, to here seems very reasonable. Best to consolidate closely-related material in one place. Klbrain (talk) 15:37, 10 February 2021 (UTC)[reply]

I find it awkward to have two or more drugboxes in one article. Also, I think it would be irritating to discuss one of the three components together with the combination, while the other two have their own articles. --ἀνυπόδητος (talk) 13:38, 18 February 2021 (UTC)[reply]

OK, closing with no merge given the uncontested objection. Klbrain (talk) 06:48, 27 July 2021 (UTC)[reply]